Vor Biopharma (VOR)

• Market cap: $641M
• 1 day: -2.89%
• 5 days: 13.95%
• 1 month: 4.61%
• 3 months: 85.35%
• 6 months: -61.4%
• Year to date: 32.65%
• 1 year: -30.45%
• 5 years: -98.39%
• 10 years: -97.94%
• Sector: Healthcare
• Industry: Biotechnology

About: Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.

Employees: 168